Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.

Bertoli S, Landberg N, Bérard E, Gondran C, Largeaud L, Mansat-De Mas V, Dumas PY, Pigneux A, Bidet A, Garciaz S, Gabellier L, Roth Guepin G, Orvain C, Peterlin P, Birsen R, Alexis M, Carré M, Tavernier E, Boissard Simonet M, Himberlin C, Maynadié M, Laribi K, Moluçon Chabrot C, Belhabri A, Chraibi S, Cabrera Q, Lebon D, Raffoux E, Cluzeau T, Micol JB, Leclerc M, Berthon C, Dombret H, Juliusson G, Robelius A, Lehmann S, Jädersten M, Vennström L, Montesinos P, Botella C, Bergua Burgues JM, Garcia R, Serrano J, Amigo ML, García Ramirez P, Sossa-Melo CL, Alonso-Domínguez JM, Döhner H, Döhner K, Späth D, Kühn MW, Lengerke C, Tischler HJ, Röllig C, Ruhnke L, Thiede C, Burchert A, Serve H, Müller-Tidow C, Baldus CD, Versluis J, Valk PJ, Kristensen DT, Stidsholt Roug A, Mayer J, Kontro M, Ettala P MD, Lazarevic VL, Récher C

Open source

DOI
10.1182/blood.2026033895
Published
2026 Sep 18
Container
Blood
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood.2026033895,
  title = {Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.},
  author = {Bertoli S and Landberg N and Bérard E and Gondran C and Largeaud L and Mansat-De Mas V and Dumas PY and Pigneux A and Bidet A and Garciaz S and Gabellier L and Roth Guepin G and Orvain C and Peterlin P and Birsen R and Alexis M and Carré M and Tavernier E and Boissard Simonet M and Himberlin C and Maynadié M and Laribi K and Moluçon Chabrot C and Belhabri A and Chraibi S and Cabrera Q and Lebon D and Raffoux E and Cluzeau T and Micol JB and Leclerc M and Berthon C and Dombret H and Juliusson G and Robelius A and Lehmann S and Jädersten M and Vennström L and Montesinos P and Botella C and Bergua Burgues JM and Garcia R and Serrano J and Amigo ML and García Ramirez P and Sossa-Melo CL and Alonso-Domínguez JM and Döhner H and Döhner K and Späth D and Kühn MW and Lengerke C and Tischler HJ and Röllig C and Ruhnke L and Thiede C and Burchert A and Serve H and Müller-Tidow C and Baldus CD and Versluis J and Valk PJ and Kristensen DT and Stidsholt Roug A and Mayer J and Kontro M and Ettala P MD and Lazarevic VL and Récher C},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2026033895},
  url = {https://doi.org/10.1182/blood.2026033895}
}

RIS

TY  - JOUR
TI  - Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.
AU  - Bertoli S
AU  - Landberg N
AU  - Bérard E
AU  - Gondran C
AU  - Largeaud L
AU  - Mansat-De Mas V
AU  - Dumas PY
AU  - Pigneux A
AU  - Bidet A
AU  - Garciaz S
AU  - Gabellier L
AU  - Roth Guepin G
AU  - Orvain C
AU  - Peterlin P
AU  - Birsen R
AU  - Alexis M
AU  - Carré M
AU  - Tavernier E
AU  - Boissard Simonet M
AU  - Himberlin C
AU  - Maynadié M
AU  - Laribi K
AU  - Moluçon Chabrot C
AU  - Belhabri A
AU  - Chraibi S
AU  - Cabrera Q
AU  - Lebon D
AU  - Raffoux E
AU  - Cluzeau T
AU  - Micol JB
AU  - Leclerc M
AU  - Berthon C
AU  - Dombret H
AU  - Juliusson G
AU  - Robelius A
AU  - Lehmann S
AU  - Jädersten M
AU  - Vennström L
AU  - Montesinos P
AU  - Botella C
AU  - Bergua Burgues JM
AU  - Garcia R
AU  - Serrano J
AU  - Amigo ML
AU  - García Ramirez P
AU  - Sossa-Melo CL
AU  - Alonso-Domínguez JM
AU  - Döhner H
AU  - Döhner K
AU  - Späth D
AU  - Kühn MW
AU  - Lengerke C
AU  - Tischler HJ
AU  - Röllig C
AU  - Ruhnke L
AU  - Thiede C
AU  - Burchert A
AU  - Serve H
AU  - Müller-Tidow C
AU  - Baldus CD
AU  - Versluis J
AU  - Valk PJ
AU  - Kristensen DT
AU  - Stidsholt Roug A
AU  - Mayer J
AU  - Kontro M
AU  - Ettala P MD
AU  - Lazarevic VL
AU  - Récher C
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2026033895
UR  - https://doi.org/10.1182/blood.2026033895
ER  -

APA

S, B., N, L., E, B., C, G., L, L., V, M. M., PY, D., A, P., A, B., S, G., L, G., G, R. G., C, O., P, P., R, B., M, A., M, C., E, T., M, B. S., C, H., M, M., K, L., C, M. C., A, B., S, C., Q, C., D, L., E, R., T, C., JB, M., M, L., C, B., H, D., G, J., A, R., S, L., M, J., L, V., P, M., C, B., JM, B. B., R, G., J, S., ML, A., P, G. R., CL, S., JM, A., H, D., K, D., D, S., MW, K., C, L., HJ, T., C, R., L, R., C, T., A, B., H, S., C, M., CD, B., J, V., PJ, V., DT, K., A, S. R., J, M., M, K., MD, E. P., VL, L., & C, R. (2026). Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.. Blood. https://doi.org/10.1182/blood.2026033895

Source records